Drawing for AQUA-FLOX

USPTO serial 85675205

AQUA-FLOX

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
KING, LINDA M
Law office
OFFICE OF TRADEMARK PROGRAM CONTROL

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AQUA-FLOX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Veterinary preparations for treatment of common bacteria infections in fishABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 19, 2013MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Jun 19, 2013ABN5ABANDONMENT - AFTER PUBLICATION—
Jun 19, 2013CORVREVIEW OF CORRESPONDENCE COMPLETE—
Jun 18, 2013ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
May 31, 2013EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Dec 27, 2012ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Dec 4, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 4, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 14, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 31, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 31, 2012DOCKASSIGNED TO EXAMINER—
Jul 19, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 16, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance